Related Experiment Videos

CI-1015. An orally active CCK-B receptor antagonist with an improved pharmacokinetic profile

B K Trivedi1, J P Hinton

  • 1Department of Medicinal Chemistry, Parke-Davis Pharmaceutical Research, Warner-Lambert Company, Ann Arbor, Michigan 48105, USA.

Pharmaceutical Biotechnology
|October 7, 1998
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos